A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes.
about
Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A ReviewSex dimorphism and depot differences in adipose tissue functionPPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytesAn adenosine receptor-Krüppel-like factor 4 protein axis inhibits adipogenesis.Identification of a novel lncRNA in gluteal adipose tissue and evidence for its positive effect on preadipocyte differentiation.25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes.Increased adipogenesis of human adipose-derived stem cells on polycaprolactone fiber matrices.The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytesOptimal protocol for the differentiation and metabolic analysis of human adipose stromal cellsDirect conversion of human myoblasts into brown-like adipocytes by engineered super-active PPARγChemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death.Improved adipogenic in vitro differentiation: comparison of different adipogenic cell culture media on human fat and bone stroma cells for fat tissue engineeringExtracellular Redox Regulation of Intracellular Reactive Oxygen Generation, Mitochondrial Function and Lipid Turnover in Cultured Human AdipocytesAdiporedoxin, an upstream regulator of ER oxidative folding and protein secretion in adipocytes.Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the antilipolytic effect of insulin in human adipocytes.Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesisDistinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots.Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity.Prolonged efficiency of siRNA-mediated gene silencing in primary cultures of human preadipocytes and adipocytes.Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients.Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes.Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance.FSP27 and PLIN1 interaction promotes the formation of large lipid droplets in human adipocytes.Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stressDetecting human coronary inflammation by imaging perivascular fat.Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue.Aortic carboxypeptidase-like protein enhances adipose tissue stromal progenitor differentiation into myofibroblasts and is upregulated in fibrotic white adipose tissue.Evaluation and optimization of differentiation conditions for human primary brown adipocytes.
P2860
Q26744739-038D9F1E-F6FF-4149-824A-A28703836A57Q26999869-E14E52C0-6F06-40B5-812B-86820A88D409Q33634827-BD9DC119-1084-4566-B0BC-83F006D1E819Q33947244-270DE33E-828B-45D6-AB47-9D0AFA49E8CAQ34495654-7AADF55E-B0D3-4B5C-B561-4B9236110AA9Q34526047-502A525A-AB38-456D-9413-130CF7A345F6Q34566523-2AD97C23-E1D6-4FEC-80F2-121EA0E3B974Q35064186-E62C51CB-8CA0-445A-9673-DAF093B2562FQ35108813-D912BBE9-8109-4DBC-97DF-6F36AF49BDB7Q35549745-AB42AFA2-7D1F-40A2-8335-ABF0DADE7AF2Q35783450-32B1B86B-B5EE-49F8-AF15-46E73A4532D1Q35808428-C01455D7-C3B6-4730-85A7-C3217EAE37E3Q36163645-6A17F2BD-5ADB-40B2-A95D-DE9FAD0D4208Q36246139-1F966E5D-C87B-4C07-9FA7-CAB604D94BCEQ36382542-553E70D9-0E31-46DD-945D-B371C647CD27Q36386362-F3F20F6F-C4C0-4F00-9FA0-1CF39C0383DDQ36508832-88241C98-DC6C-4B7C-92B1-B157F163518BQ37033146-BD220059-1B4B-4549-8811-4D95A2A29CA9Q37669654-1E8068BD-7C42-47C1-9FEC-2C3C16D08732Q37716083-56CED0CD-A800-4C7C-8426-13D584DD91D7Q37727642-1356A6B1-632F-4F54-8FF3-164C619C140BQ40986711-498A50BE-9F48-4A72-9EF7-FBFB87A3489CQ41227900-84B77955-2325-43AC-A657-4D1A810C2564Q42578865-0A8AD01F-AF7F-487D-8044-7F4217259F2CQ48136703-DED931C3-4E6A-4CC7-9AB1-D79CDCD8FBD7Q50990192-9D497E9D-E187-445E-A6AF-42630C5BAC9AQ53181183-833520CD-76DD-4DFC-8B59-0581DEB7ACCEQ54978248-2BF09B03-16D6-4D44-8F65-B06F0A668322Q55384230-E2343574-F054-4551-AA98-E9003E81FCC8
P2860
A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A modified protocol to maximiz ...... improve metabolic phenotypes.
@ast
A modified protocol to maximiz ...... improve metabolic phenotypes.
@en
type
label
A modified protocol to maximiz ...... improve metabolic phenotypes.
@ast
A modified protocol to maximiz ...... improve metabolic phenotypes.
@en
prefLabel
A modified protocol to maximiz ...... improve metabolic phenotypes.
@ast
A modified protocol to maximiz ...... improve metabolic phenotypes.
@en
P2860
P356
P1433
P1476
A modified protocol to maximiz ...... d improve metabolic phenotypes
@en
P2093
Yuanyuan Wu
P2860
P304
P356
10.1038/OBY.2012.116
P577
2012-05-04T00:00:00Z